Related Experiment Videos
[Systematic hysteroscopy prior to in vitro fertilization].
J Féghali1, J Bakar, J M Mayenga
1Service de gynécologie-obstétrique, centre hospitalier intercommunal Jean-Rostand, 141, Grande-Rue, 92318 cedex, Sèvres, France.
Gynecologie, Obstetrique & Fertilite
|April 30, 2003
Summary
Diagnostic hysteroscopy before in vitro fertilization (IVF) identifies uterine pathologies in 45% of cases. Treating these conditions, like endometritis, can improve IVF pregnancy rates, making hysteroscopy a valuable pre-treatment investigation.
Area of Science:
- Reproductive Medicine
- Gynecological Surgery
- Infertility Diagnostics
Background:
- Uterine cavity assessment is crucial for successful in vitro fertilization (IVF).
- Diagnostic hysteroscopy offers a direct visualization of the uterine lining.
- Pre-IVF screening protocols aim to optimize implantation rates.
Purpose of the Study:
- To evaluate the diagnostic utility and benefits of hysteroscopy before IVF.
- To determine the prevalence of intrauterine pathologies in infertile patients undergoing IVF.
- To assess the impact of hysteroscopy-guided treatment on IVF pregnancy outcomes.
Main Methods:
- Retrospective study of 145 patients undergoing intracytoplasmic sperm injection (ICSI).
- Systematic office hysteroscopy performed before the initial IVF stimulation cycle.
- Pathological findings were treated medically or surgically prior to embryo transfer.
Main Results:
- Hysteroscopy revealed pathologies in 45% of patients, with endometritis, polyps, and myomas being most common.
- No significant difference in pathology rates was observed between patients over 38 and younger patients.
- Treatment of pathologies resulted in pregnancy rates comparable to those with normal uterine cavities; 40% of endometritis patients conceived post-antibiotic treatment.
Conclusions:
- Systematic pre-IVF hysteroscopy is an effective diagnostic tool.
- Identifying and treating intrauterine pathologies can potentially enhance IVF-ICSI pregnancy rates.
- Hysteroscopy should be considered as part of the routine infertility workup prior to assisted reproductive technologies.